Day: October 30, 2020

TAMPA, Fla. and OCALA, Fla., Oct. 30, 2020 (GLOBE NEWSWIRE) — BioFlorida has announced Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech Inc. (NYSE American: AIM), as its Weaver H. Gaines Entrepreneur of the Year. The Entrepreneur of the Year Award recognizes an entrepreneur who has made extraordinary contributions to the growth of life sciences in the leadership of a company or institution. BioFlorida represents 6,700 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors.Thomas K. Equels is the CEO of AIM ImmunoTech Inc., an Ocala, Fla.-based immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus....

STAMFORD, Conn., Oct. 30, 2020 (GLOBE NEWSWIRE) — Sourcing industry experts will explore enterprise buyer trends and strategies for provider success at the 2020 ISG Sourcing Industry Conference (SIC), the premier annual event for service and technology providers hosted by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm.“Service and technology providers are essential partners for enterprises focused on operational resiliency and business continuity,” said Steve Hall, president of ISG. “New ISG Index™ data show the global sourcing industry is slowly recovering from its pandemic-induced downturn, with robust transaction volume as enterprises shift to virtual models that are accelerating their digital transformations.”The 2020 ISG Sourcing Industry Conference will be the first to...

What you need to know:            º  Verizon is implementing a blockchain-verified record of changes to its news releases            º  The Full Transparency initiative is a proof of concept built with open-source blockchain technology in partnership with Huge, MadNetwork and AdLedger            º  The Full Transparency initiative has the potential to change the way companies communicate to their audiencesBASKING RIDGE, N.J., Oct. 30, 2020 (GLOBE NEWSWIRE) — Verizon today announced the launch of Full Transparency by Verizon, a blockchain-based, open-source newsroom product designed to raise the bar for corporate accountability. This initiative seeks to transform how the Verizon Corporate Newsroom publishes news releases by providing an authoritative record of changes to public communications.A lack of transparency has the potential...

Preliminary financial data of Ignitis Group (hereinafter – the Group) for 9 months of 2020:In January – September 2020, the Group generated revenue of EUR 874.1 million, which is 8.9 % more compared to a respective period of 2019 (EUR 802.5 million). The Group’s revenue has increased mainly due to price of power distribution service, which is comprised of power transmission, distribution and public service obligations (PSO) components.The adjusted EBITDA indicator of the Group in January – September 2020 was equal to EUR 199.3 million, i.e. 6.1 % more compared to a respective period of 2019 (EUR 187.8 million). It was mostly the result of the growing value of regulated assets due to investments in the renewal of distribution networks and efficient use of Kruonis PSHP and Elektrėnai Complex.*The Company’s preliminary (2020)...

2020 metų 9 mėnesių preliminarūs „Ignitis grupės“ įmonių grupės (toliau – Grupės) finansiniai duomenys:Grupės pajamos 2020 m. sausio-rugsėjo mėn. siekė 874,1 mln. eurų ir buvo 8,9 proc. didesnės palyginus su atitinkamu laikotarpiu 2019 m. (802,5 mln. eurų). Esminė Grupės pajamų augimą lėmusi priežastis buvo elektros energijos persiuntimo paslaugos, kurią sudaro elektros perdavimo, skirstymo ir viešuosius interesus atitinkančių paslaugų (VIAP) dedamosios, kaina.Grupės koreguotas EBITDA rodiklis 2020 m. sausio-rugsėjo mėn. siekė 199,3 mln. eurų ir buvo 6,1 proc. didesnis palyginus su atitinkamu laikotarpiu 2019 m. (187,8 mln. eurų). Tokią rodiklio dinamiką išlaikyti padeda dėl investicijų į skirstomųjų tinklų atnaujinimą auganti reguliuojamo turto vertė bei efektyvus Kruonio HAE ir Elektrėnų komplekso panaudojimas.*Bendrovės preliminarus...

Preliminary financial data of Ignitis Group (hereinafter – the Group) for 9 months of 2020:In January – September 2020, the Group generated revenue of EUR 874.1 million, which is 8.9 % more compared to a respective period of 2019 (EUR 802.5 million). The Group’s revenue has increased mainly due to price of power distribution service, which is comprised of power transmission, distribution and public service obligations (PSO) components.The adjusted EBITDA indicator of the Group in January – September 2020 was equal to EUR 199.3 million, i.e. 6.1 % more compared to a respective period of 2019 (EUR 187.8 million). It was mostly the result of the growing value of regulated assets due to investments in the renewal of distribution networks and efficient use of Kruonis PSHP and Elektrėnai Complex.*The Company’s preliminary (2020)...

Conference call to be held Friday, November 6, at 8:15 a.m. Eastern TimeATLANTA, GA, Oct. 30, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, announces today that it plans to report third quarter 2020 financial results on Thursday, November 5, 2020 after the market closes.Management will host a conference call at 8:15 a.m. ET on Friday, November 6, 2020 to review financial results and provide an update on corporate developments.  Following management’s formal remarks, there will be a question and answer session.Participants are asked to pre-register for the call via the following link: https://dpregister.com/sreg/10149661/dc8783c368Please note that registered...

San Antonio, Texas, Oct. 30, 2020 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (Nasdaq: GROW) will host a webcast on Friday, November 6, 2020, at 7:30 a.m. Central time to discuss the company’s results for first quarter 2021.­Financial data for the quarter will be released prior to the webcast.Frank Holmes, CEO and chief investment officer, will provide an update on the company’s profitability and strong performance of its investment products. Lisa Callicotte, chief financial officer, will give an overview of financial highlights for quarter ended September 30, 2020. Lastly, Holly Schoenfeldt, marketing and public relations manager, will detail the company’s media and marketing strategy.Click here to register for the webcast.Visit www.usfunds.com for more information about U.S. Global Investors.About U.S. Global Investors, Inc.The...

Potential first-in-class treatment for hypertrophic scars with no FDA-approved medicines to to-datePhase 2a trial follows the successful completion of OliX’s Phase 1 trial in the U.K. in November 2019OliX retains global rights to develop and commercialize OLX10010 outside AsiaSUWON, Republic of Korea, Oct. 30, 2020 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application to evaluate the efficacy of OLX10010 as an adjunct therapy to reduce the recurrence of hypertrophic scars after scar revision surgery.“We are pleased to receive FDA clearance to advance investigation of OLX10010 and look forward to working with investigators to begin enrolling patients...

– Fourth Quarter Gross Margin Improved to 56% –– Positive Adjusted EBITDA Achieved in Fourth Quarter –SAN ANTONIO, Texas, Oct. 30, 2020 (GLOBE NEWSWIRE) — Digerati Technologies, Inc. (OTCQB: DTGI) (“Digerati” or the “Company”), a provider of cloud services specializing in UCaaS (Unified Communications as a Service) solutions for the small to medium-sized business (“SMB”) market, announced today financial results for the three months and twelve months ended July 31, 2020, the Company’s fourth quarter and Fiscal Year 2020 respectively.Key Financial Highlights for Fiscal Year 2020 (Ended July 31, 2020)Revenue increased to $6.279 million compared to $6.040 million for FY2019, driven by organic growth.Gross profit increased to $3.244 million compared to $2.912 million for FY2019.Gross margin...